NCT04740164View on ClinicalTrials.gov

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions
Bile Duct CarcinomaGallbladder CarcinomaPancreatic Ductal Adenocarcinoma
Interventions
PROCEDURE

Endoscopic Retrograde Cholangiopancreatography

Undergo ERCP with LMA Gastro

PROCEDURE

Endoscopic Retrograde Cholangiopancreatography

Undergo ERCP with standard nasal cannula

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT04740164 - A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP | Biotech Hunter | Biotech Hunter